International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Oncol Rep 42: [Related article:] 1141–1148, 2019; DOI: 10.3892/or.2019.7220
Subsequently to the publication of the above paper, an interested reader drew to the authors' and the Editor's attention that the clone image featured in Fig. 4A for the ‘NC’ (or ‘negative control’) data panel on p. 1146 had also been featured as the ‘NC’ experimental data panel in Fig. 4A of another article entitled ‘Interleukin 1β/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy’ (DOI: 10.3892/or.2020.7475), which was published by the same research group in the same journal.
In this pair of articles, the authors were researching IL-17F and IL-1B/1RA, respectively; all experiments were performed on interleukins using the same batch of cells, and it was the authors’ intention to have included these data, as they were portrayed, in both articles. However, to avoid any possible confusion, the authors now present alternative data for the ‘NC’ experiment in Fig. 4A for the above article, and the revised figure is shown on the next page.
In addition, the authors have realized that the data panel in Fig. 1C on p. 1144, which was intended to represent the ‘Tumor’ immunohistochemical experiment (right-hand panel), was inadvertently chosen incorrectly. The correct data for this panel is shown in the revised version of Fig. 1 opposite. Note that this error did not affect either the results or the conclusions reported in this paper. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum, and they apologize to the Editor and to the readership for any inconvenience caused.